NCT01087502 · Interventional trial
Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
Overall registry status Completed
Phase 3
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- 1218.64.10013 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
- 1218.64.10020 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory